These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32405281)
21. SARS-CoV-2 immunogenicity at the crossroads. Karamloo F; König R Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346 [No Abstract] [Full Text] [Related]
22. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century. Asrani P; Hasan GM; Sohal SS; Hassan MI OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573 [TBL] [Abstract][Full Text] [Related]
23. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Davidson AM; Wysocki J; Batlle D Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855 [TBL] [Abstract][Full Text] [Related]
24. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2. Qiu Y; Zhao YB; Wang Q; Li JY; Zhou ZJ; Liao CH; Ge XY Microbes Infect; 2020; 22(4-5):221-225. PubMed ID: 32199943 [TBL] [Abstract][Full Text] [Related]
25. COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans. Frutos R; Serra-Cobo J; Chen T; Devaux CA Infect Genet Evol; 2020 Oct; 84():104493. PubMed ID: 32768565 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
27. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141 [TBL] [Abstract][Full Text] [Related]
28. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Benetti E; Tita R; Spiga O; Ciolfi A; Birolo G; Bruselles A; Doddato G; Giliberti A; Marconi C; Musacchia F; Pippucci T; Torella A; Trezza A; Valentino F; Baldassarri M; Brusco A; Asselta R; Bruttini M; Furini S; Seri M; Nigro V; Matullo G; Tartaglia M; Mari F; ; Renieri A; Pinto AM Eur J Hum Genet; 2020 Nov; 28(11):1602-1614. PubMed ID: 32681121 [TBL] [Abstract][Full Text] [Related]
29. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249 [TBL] [Abstract][Full Text] [Related]
30. Profile of a killer: the complex biology powering the coronavirus pandemic. Cyranoski D Nature; 2020 May; 581(7806):22-26. PubMed ID: 32367025 [No Abstract] [Full Text] [Related]
31. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
32. Genetic predisposition models to COVID-19 infection. Darbeheshti F; Rezaei N Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414 [No Abstract] [Full Text] [Related]
33. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. Ferrandi PJ; Alway SE; Mohamed JS J Appl Physiol (1985); 2020 Oct; 129(4):864-867. PubMed ID: 32673162 [No Abstract] [Full Text] [Related]
34. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
35. Let's talk about sex in the context of COVID-19. Gargaglioni LH; Marques DA J Appl Physiol (1985); 2020 Jun; 128(6):1533-1538. PubMed ID: 32437244 [TBL] [Abstract][Full Text] [Related]
37. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Zu S; Deng YQ; Zhou C; Li J; Li L; Chen Q; Li XF; Zhao H; Gold S; He J; Li X; Zhang C; Yang H; Cheng G; Qin CF Cell Res; 2020 Nov; 30(11):1043-1045. PubMed ID: 32811977 [No Abstract] [Full Text] [Related]
38. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Singh KK; Chaubey G; Chen JY; Suravajhala P Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Sawalha AH; Zhao M; Coit P; Lu Q Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140 [TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Delpino MV; Quarleri J Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]